| Dr Matthew Narron, PSYD | |
|
193 Fairview Ln Ste K, Sonora, CA 95370-4828 | |
| (209) 536-5144 | |
| Not Available |
| Full Name | Dr Matthew Narron |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 19 Years |
| Location | 193 Fairview Ln Ste K, Sonora, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881831659 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PSY21288 (California) | Secondary |
| 103TC0700X | Psychologist - Clinical | PSY21288 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sonora Community Hospital | 4284538505 | 117 |
News Archive
Studies examining the effects of the use of postmenopausal hormone therapy on coronary heart disease (CHD) have yielded mixed results, depending on the type of study conducted. There may be a number of reasons for the differences, including the timing of initiation of hormone therapy, according to background information in the article.
Massachusetts health insurers' reluctance to join a national experiment to improve care for disabled lower-income adults has forced the state to scale back the program even before it starts. Massachusetts is among the first states to roll out the national program, but half the insurers that were expected to participate backed out because they feared losing money. That will mean fewer options for patients when enrollment opens for the voluntary "One Care" program in October (Conaboy, 7/29).
The mere thought of an identification error sends a chill down the spine of any mushroom lover: The death cap mushroom (Amanita phalloides), which resembles the common white button mushroom, contains one of the most deadly poisons found in nature, α-amanitin.
Cell Therapeutics, Inc. has received fast track designation from the U.S. Food and Drug Administration (FDA) for pixantrone, a novel anthracenedione, being investigated for the potential treatment of relapsed, aggressive non-Hodgkin's lymphoma (NHL).
DeNovix's DS-11 FX+ Series of Spectrophotometers / Fluorometers was awarded runner-up position in the annual Scientists Choice Awards® Best New Life Sciences Product 2015. The award was presented during this year's American Association for Cancer Research (AACR) annual meeting.
› Verified 3 days ago
| Entity Name | Sonora Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891732418 PECOS PAC ID: 4284538505 Enrollment ID: O20031119000910 |
News Archive
Studies examining the effects of the use of postmenopausal hormone therapy on coronary heart disease (CHD) have yielded mixed results, depending on the type of study conducted. There may be a number of reasons for the differences, including the timing of initiation of hormone therapy, according to background information in the article.
Massachusetts health insurers' reluctance to join a national experiment to improve care for disabled lower-income adults has forced the state to scale back the program even before it starts. Massachusetts is among the first states to roll out the national program, but half the insurers that were expected to participate backed out because they feared losing money. That will mean fewer options for patients when enrollment opens for the voluntary "One Care" program in October (Conaboy, 7/29).
The mere thought of an identification error sends a chill down the spine of any mushroom lover: The death cap mushroom (Amanita phalloides), which resembles the common white button mushroom, contains one of the most deadly poisons found in nature, α-amanitin.
Cell Therapeutics, Inc. has received fast track designation from the U.S. Food and Drug Administration (FDA) for pixantrone, a novel anthracenedione, being investigated for the potential treatment of relapsed, aggressive non-Hodgkin's lymphoma (NHL).
DeNovix's DS-11 FX+ Series of Spectrophotometers / Fluorometers was awarded runner-up position in the annual Scientists Choice Awards® Best New Life Sciences Product 2015. The award was presented during this year's American Association for Cancer Research (AACR) annual meeting.
› Verified 3 days ago
| Entity Name | Sonora Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033100854 PECOS PAC ID: 4284538505 Enrollment ID: O20040316000829 |
News Archive
Studies examining the effects of the use of postmenopausal hormone therapy on coronary heart disease (CHD) have yielded mixed results, depending on the type of study conducted. There may be a number of reasons for the differences, including the timing of initiation of hormone therapy, according to background information in the article.
Massachusetts health insurers' reluctance to join a national experiment to improve care for disabled lower-income adults has forced the state to scale back the program even before it starts. Massachusetts is among the first states to roll out the national program, but half the insurers that were expected to participate backed out because they feared losing money. That will mean fewer options for patients when enrollment opens for the voluntary "One Care" program in October (Conaboy, 7/29).
The mere thought of an identification error sends a chill down the spine of any mushroom lover: The death cap mushroom (Amanita phalloides), which resembles the common white button mushroom, contains one of the most deadly poisons found in nature, α-amanitin.
Cell Therapeutics, Inc. has received fast track designation from the U.S. Food and Drug Administration (FDA) for pixantrone, a novel anthracenedione, being investigated for the potential treatment of relapsed, aggressive non-Hodgkin's lymphoma (NHL).
DeNovix's DS-11 FX+ Series of Spectrophotometers / Fluorometers was awarded runner-up position in the annual Scientists Choice Awards® Best New Life Sciences Product 2015. The award was presented during this year's American Association for Cancer Research (AACR) annual meeting.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Narron, PSYD 16525 Creekside Dr, Sonora, CA 95370-7931 Ph: (510) 499-3666 | Dr Matthew Narron, PSYD 193 Fairview Ln Ste K, Sonora, CA 95370-4828 Ph: (209) 536-5144 |
News Archive
Studies examining the effects of the use of postmenopausal hormone therapy on coronary heart disease (CHD) have yielded mixed results, depending on the type of study conducted. There may be a number of reasons for the differences, including the timing of initiation of hormone therapy, according to background information in the article.
Massachusetts health insurers' reluctance to join a national experiment to improve care for disabled lower-income adults has forced the state to scale back the program even before it starts. Massachusetts is among the first states to roll out the national program, but half the insurers that were expected to participate backed out because they feared losing money. That will mean fewer options for patients when enrollment opens for the voluntary "One Care" program in October (Conaboy, 7/29).
The mere thought of an identification error sends a chill down the spine of any mushroom lover: The death cap mushroom (Amanita phalloides), which resembles the common white button mushroom, contains one of the most deadly poisons found in nature, α-amanitin.
Cell Therapeutics, Inc. has received fast track designation from the U.S. Food and Drug Administration (FDA) for pixantrone, a novel anthracenedione, being investigated for the potential treatment of relapsed, aggressive non-Hodgkin's lymphoma (NHL).
DeNovix's DS-11 FX+ Series of Spectrophotometers / Fluorometers was awarded runner-up position in the annual Scientists Choice Awards® Best New Life Sciences Product 2015. The award was presented during this year's American Association for Cancer Research (AACR) annual meeting.
› Verified 3 days ago
Alexandra Union, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 193 Fairview Ln Ste F, Sonora, CA 95370 Phone: 209-536-5110 Fax: 209-588-8685 | |
Dr. Rebecca Ann Dodge, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 86 South Steward Street, Suite 201, Sonora, CA 95370 Phone: 209-532-5132 Fax: 209-532-1348 | |
Christopher Mankowski, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 103 S Forest Rd, Sonora, CA 95370 Phone: 707-217-3087 | |
Dr. Arlene S Giordano, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 101 S Forest Rd, Sonora, CA 95370 Phone: 209-533-2137 Fax: 209-532-3929 | |
Mrs. Darellea Keshner, MA LMFT LEP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 101 S Forest Rd, Sonora, CA 95370 Phone: 209-499-4079 | |
Dr. Susan Belle Day, PH.D., RN, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 103 S Forest Rd, Sonora, CA 95370 Phone: 209-533-1699 Fax: 209-532-0699 | |
Joseph Culley Harrelson, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 103 S Forest Rd, Sonora, CA 95370 Phone: 209-533-1699 |